secwatch.observer — SEC 8-K summary
======================================

Issuer:     Korro Bio, Inc. (KRRO)
CIK:        0001703647
Form:       8-K
Filed at:   2026-01-27T23:59:59+00:00
Accession:  0001193125-26-023436
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Korro Bio holds Analyst Day highlighting KRRO-121 for ammonia control
---------------------------------------------------------------------

- Hosted virtual Analyst Day on Jan 27, 2026, presenting on KRRO-121 for ammonia control.
- KRRO-121 described as a potential first-in-class treatment for ammonia control.
- No specific clinical data or milestones disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703647/000119312526023436/0001193125-26-023436-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703647/000119312526023436/krro-20260127.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-023436

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer